Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome

References

• Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481–8
   PubMed Web of Science ®Google Scholar
• Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919–32
   PubMed Web of Science ®Google Scholar
• Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020–7
   PubMed Web of Science ®Google Scholar
• Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829–34
   PubMed Web of Science ®Google Scholar
• de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006; 130: 665–71
   PubMed Web of Science ®Google Scholar
• Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424–5
   PubMed Web of Science ®Google Scholar
• Kievit W, de Bruin JH, Adang EM, Ligtenberg MJ, Nagengast FM, van Krieken JH, et al. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis. Clin Genet 2004; 65: 308–16
   PubMedGoogle Scholar
• Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006; 296: 1507–17
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89: 1758–62
   PubMedGoogle Scholar
• Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261–8
   PubMed Web of Science ®Google Scholar
• Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH, et al. Cost effectiveness of a new strategy to identify HNPCC patients. Gut 2005; 54: 97–102
   PubMed Web of Science ®Google Scholar
• de Bruin JH, Ligtenberg MJ, Nagengast FM, Adang EM, van Krieken JH, Hoogerbrugge N. Optimizing the detection of hereditary non-polyposis colorectal cancer: an update. Scand J Gastroenterol 2006; Suppl 243: 146–52
   Google Scholar
• van Dijk DA, Oostindier MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF. Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 2007; 6: 131–4
   PubMedGoogle Scholar
• Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008; 26(35)5783–8
   PubMed Web of Science ®Google Scholar
• Pinol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005; 293(16): 1986–94
   Google Scholar
• Rodriguez-Moranta F, Castells A, Andreu M, Pinol V, Castellvi-Bel S, Alenda C, et al. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am J Gastroenterol 2006; 101: 1104–11
   PubMedGoogle Scholar
• Balmana J, Balaguer F, Castellvi-Bel S, Steyerberg EW, Andreu M, Llor X, et al. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet 2008; 45: 557–63
   PubMedGoogle Scholar
• Wolf B, Gruber S, Henglmueller S, Kappel S, Bergmann M, Wrba F, et al. Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations in mismatch repair genes in Austrian HNPCC patients. Int J Cancer 2006; 118: 1465–70
   PubMedGoogle Scholar
• Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007; 133: 48–56
   PubMed Web of Science ®Google Scholar
• Church J, McGannon E. Family history of colorectal cancer: how often and how accurately is it recorded?. Dis Colon Rectum 2000; 43: 1540–4
   PubMed Web of Science ®Google Scholar
• Katballe N, Juul S, Christensen M, Orntoft TF, Wikman FP, Laurberg S. Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members. Br J Surg 2001; 88: 1228–33
   PubMed Web of Science ®Google Scholar
• Sijmons RH, Boonstra AE, Reefhuis J, Hordijk-Hos JM, de Walle HE, Oosterwijk JC, et al. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet 2000; 8: 181–6
   PubMed Web of Science ®Google Scholar
• de la Chapelle A. The incidence of Lynch syndrome. Fam Cancer 2005; 4: 233–7
   PubMedGoogle Scholar
• Schroy PC III, Barrison AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 2002; 97: 1031–6
   PubMed Web of Science ®Google Scholar
• Alberto VO, Harocopos CJ, Patel AA, Clark SK. Family and personal history in colorectal cancer patients: what are we missing?. Colorectal Dis 2006; 8: 612–4
   PubMedGoogle Scholar